Skip to main content
Clinical Trials/JPRN-UMIN000049052
JPRN-UMIN000049052
Recruiting
未知

Exploratory study of a new phenotyping method for the evaluation of CYP1A2 activity - Exploratory study to evaluate CYP1A2 activity

Tokyo University of Pharmacy and Life Sciences0 sites18 target enrollmentOctober 1, 2022
Conditionshealthy subject

Overview

Phase
未知
Intervention
Not specified
Conditions
healthy subject
Sponsor
Tokyo University of Pharmacy and Life Sciences
Enrollment
18
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 1, 2022
End Date
August 31, 2025
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Persons who do not consume caffeine\-containing products (coffee, tea, soft drinks) on a daily basis (2 to 3 times a week). 2\) Persons who have experienced adverse reactions (palpitations, nausea, etc.) to caffeine\-containing products (coffee, tea, soft drinks). Persons who are allergic to caffeine 3\) Persons who have ever felt sick from blood sampling. 4\) Persons who are under medical treatment, pregnant women or those who are thought to be pregnant or nursing 5\) Persons who have subjective symptoms of hyperacidity on interview, persons who have been diagnosed with heart disease or gastric ulcer

Outcomes

Primary Outcomes

Not specified

Similar Trials